📰 Bridge Access Program News
Page 45 - Bridge Access Program News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Bridge Access Program. Real-time updates on events, politics, business and more.
September 12, 2023
By Stacy M. Brown | NNPA - The FDA has approved updated COVID-19 vaccines from Moderna and Pfizer/BioNTech, which are available for administration to individuals 12 and older, with emergency use authorization for individuals six months to 11 years.
September 12, 2023
The endorsement from the committee means the vaccines will be covered by public and private insurance plans.
September 12, 2023
The CDC formally recommended the updated Pfizer-BioNTech and Moderna boosters, which means jabs can ship to pharmacies across the country within days.
September 12, 2023
The newest CDC recommendations will make a new shots available as early as this week.
September 12, 2023
Committee members raised concerns that a more graded recommendation would contribute to inequity
September 12, 2023
(CNN) — The US Centers for Disease Control and Prevention’s independent vaccine advisers voted 13-1 on Tuesday to recommend updated Covid-19 vaccines for all Americans 6 months of age<a class="excerpt-read-more" href="https://whdh.com/news/cdc-advisers-recommend-updated-covid-19-vaccines/">Read More</a>
September 12, 2023
The CDC still needs to sign off on shots for everyone 6 months and up. Heres what to know about the new vaccines, when you can get one and how much theyll cost.
September 12, 2023
New vaccines will be available by the end of week.
September 12, 2023
The Food and Drug Administration on Monday approved updated Covid vaccines from Pfizer and Moderna. The U.S. Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices approved the vaccines on Tuesday. The newly approved vaccine is for individuals 12 years and older and granted emergency use authorization for individuals 6 months through 11 years of age.
September 12, 2023
The new shots are similar to previously approved formulas but were updated to target strains of the virus descended from Omicron.